treosulfan has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frączkiewicz, J; Gajek, K; Kałwak, K; Mielcarek-Siedziuk, M; Raciborska, A; Rosa, M; Rybka, B; Ryczan-Krawczyk, R; Salamonowicz, M; Ślęzak, A; Ussowicz, M; Wawrzyniak-Dzierżek, E; Węcławek-Tompol, J | 1 |
| Boos, J; Bremer, A; Dirksen, U; Jürgens, H; Lanvers-Kaminsky, C | 1 |
1 trial(s) available for treosulfan and Neuroblastoma
| Article | Year |
|---|---|
Feasibility and Safety of Treosulfan, Melphalan, and Thiotepa-Based Megachemotherapy with Autologous or Allogeneic Stem Cell Transplantation in Heavily Pretreated Children with Relapsed or Refractory Neuroblastoma.
Topics: Allografts; Antineoplastic Combined Chemotherapy Protocols; Autografts; Busulfan; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Male; Melphalan; Neuroblastoma; Recurrence; Stem Cell Transplantation; Survival Rate; Thiotepa | 2019 |
1 other study(ies) available for treosulfan and Neuroblastoma
| Article | Year |
|---|---|
Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines.
Topics: Antineoplastic Agents, Alkylating; Bone Neoplasms; Busulfan; Cell Survival; Humans; Leukemia; Neuroblastoma; Osteosarcoma; Sarcoma, Ewing; Tumor Cells, Cultured | 2006 |